Immediate Versus Delayed Surgical Reconstruction of Peri-implantitis Intra-bony Defects.
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT07325747
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Staged peri-implant debridement and regeneration — PROCEDUREPeri-implant debridement will be carried our in visit one and will be followed by a second surgery for regeneration
- Simultaneous peri-implant debridement and regeneration — PROCEDUREThe peri-implant defect will be debrided and regenerated at the same visit.
Study Details
The purpose of this study is to test the comparative efficacy of two surgical approaches (immediate versus delayed GBR) for the surgical reconstruction of peri-implantitis intra-bony defects in terms of the clinical, radiographical, histological, volumetric, microbiological, and patient-reported outcomes. The investigators hypothesize that in certain clinical situations, treatment of peri-implantitis intra-bony defects with the use of a compound bone grafting material (mixture of allogenic bone substitutes) and a non-resorbable barrier membrane and following a delayed approach (test group) with initial phase of defect decontamination and initial healing phase would yield superior outcomes to that of the conventional approach (control group) of defect decontamination and regeneration at the same clinical visit while also significantly enhancing patient-reported outcomes: H0: There is no difference between the two mentioned approaches in terms of the treatment outcomes. H1: There is a significant difference, favoring the delayed approach compared to the immediate reconstruction.
Key Dates
- Start date
- Jan 12, 2026
- Status verified
- Dec 2025
- Primary completion
- Feb 28, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Control GroupThe subjects will receive treatment consisting of surgical defect debridement and decontamination, followed by intra-bony defect reconstruction via immediate guided bone regeneration (GBR).
- Experimental: Test GroupThe subjects will receive a two-stage treatment consisting of the surgical removal of peri-implant granulation tissue and pocket epithelium. After 4-6 weeks, they will undergo surgical defect debridement and decontamination, followed by intra-bony defect reconstruction via immediate guided bone regeneration (GBR).
Primary Outcome Measure
Radiographic change [ Time Frame: 12 months ]
Central Contacts
- Purnima Kumar, DDS, PhD17347632105
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan School of Dentistry | Ann Arbor | Michigan | 48109 | Purnima Kumar, BDS, MS, PhD (PRINCIPAL_INVESTIGATOR) Muhammad Saleh, BDS, MSD (SUB_INVESTIGATOR) Paolo Nava, DDS (SUB_INVESTIGATOR) Hamoun Sabri, DMD, PgC (SUB_INVESTIGATOR) Yousef Amrou, DDS (SUB_INVESTIGATOR) Khushboo Kalani, DDS (SUB_INVESTIGATOR) Tamires Dutra, DDS, MS, PhD (SUB_INVESTIGATOR) Aster Vas, DDS (SUB_INVESTIGATOR) |